Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
They are supplied exclusively for in-vitro and pre-clinical research purposes
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
2019;4(19):e127647
O., Biessmann, A., & Brandt, I
Proven Results Users report increased energy and mental clarity in just weeks
The SELECT trial demonstrated that semaglutide 2.4 mg weekly reduced cardiovascular events in adults with established cardiovascular disease and either overweight or obesity
US$ 23.81
US$ 23.18
US$ 20.65
US$ 29.08
US$ 21.79
US$ 23.75
US$ 20.05
US$ 27.78
